Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Falchero

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Current Oncology (Toronto, Ont.)|November 23, 2018
Patients with non-small-cell lung cancer harbouring a <i>BRAF</i> mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14J B Auliac, S Bayle, A Vergnenegre, et al.
Respiratory Medicine Case Reports|September 14, 2019
Clinical ACO phenotypes: Description of a heterogeneous entityS Lainez, I Court-Fortune, P Vercherin, et al.
Revue De Pneumologie Clinique|March 18, 2005
[Treatment of anemia and bone metastasis in metastatic non-small-cell lung cancer. A French survey]J-M Brechot, N Roche, C Marichy, et al.
Revue Des Maladies Respiratoires|June 16, 2022
[Systemic nocardiosis with mediastinal lymph node involvement proven by endoscopic ultrasound]S Storme, R Bricca, C M Gaillard, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary resultsM P Sunyach, L Falchero, P Pommier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2006
Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC studyA B Cortot, L Gerinière, G Robinet, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 studyJ B Auliac, C Chouaid, L Greillier, et al.
ESMO Open|July 24, 2025
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysisK Amrane, B Cabarrou, G Justeau, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Current Oncology (Toronto, Ont.)|November 23, 2018
Patients with non-small-cell lung cancer harbouring a <i>BRAF</i> mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14J B Auliac, S Bayle, A Vergnenegre, et al.
Respiratory Medicine Case Reports|September 14, 2019
Clinical ACO phenotypes: Description of a heterogeneous entityS Lainez, I Court-Fortune, P Vercherin, et al.
Revue De Pneumologie Clinique|March 18, 2005
[Treatment of anemia and bone metastasis in metastatic non-small-cell lung cancer. A French survey]J-M Brechot, N Roche, C Marichy, et al.
Revue Des Maladies Respiratoires|June 16, 2022
[Systemic nocardiosis with mediastinal lymph node involvement proven by endoscopic ultrasound]S Storme, R Bricca, C M Gaillard, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary resultsM P Sunyach, L Falchero, P Pommier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2006
Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC studyA B Cortot, L Gerinière, G Robinet, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 studyJ B Auliac, C Chouaid, L Greillier, et al.
ESMO Open|July 24, 2025
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysisK Amrane, B Cabarrou, G Justeau, et al.
Pageof 2